Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.21.1
Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Statements of Operations    
Grant revenue $ 242,061 $ 0
Cost of grant revenue 242,061 0
Gross profit 0 0
Operating expenses:    
Research and development 260,880 350,664
General and administrative 600,686 579,770
Sales and marketing 62,578 0
Total operating expenses 924,144 930,434
Loss from operations (924,144) (930,434)
Other expenses:    
Interest expense, net 6 67
Net loss $ (924,150) $ (930,501)
Net loss per share - basic and fully diluted $ (0.17) $ (0.31)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 5,344,025 2,968,394